Causes of death and life span in Finnish gelsolin amyloidosis

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1:314–24.
   PubMedGoogle Scholar
• Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand. 1992;86:346–53.
   PubMed Web of Science ®Google Scholar
• Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. In: Said G, Krarup C, eds. Peripheral nerve disorders, Volume 115, Handbook of clinical neurology, pp. 659–81. Amsterdam: Elsevier, 2013.
   Google Scholar
• Kwiatkowski D, Westbrook C, Bruns G, Morton C. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet. 1988;42:565–72.
   PubMed Web of Science ®Google Scholar
• Haltia M, Levy E, Meretoja J, Fernandez‐Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation-at codon 187-in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet. 1992;42:357–9.
   PubMed Web of Science ®Google Scholar
• Maramattom BV, Chickabasaviah YT. A new Indian family affected by gelsolin amyloidosis. Neurol India. 2013;61:673–5.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez J, Ramirez-Miranda A, Hernandez-Da Mota SE, Zenteno JC. TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies. Graefes Arch Clin Exp Ophthalmol. 2014;252:1267–72.
   PubMed Web of Science ®Google Scholar
• Nikoskinen T, Schmidt EK, Strbian D, Kiuru-Enari S, Atula S. Natural course of Finnish gelsolin amyloidosis. Ann Med. 2015;47:506–11.
   PubMed Web of Science ®Google Scholar
• Solomon JP, Page LJ, Balch WE, Kelly JW. Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Crit Rev Biochem Mol Biol. 2012;47:282–96.
   PubMed Web of Science ®Google Scholar
• Van Overbeke W, Verhelle A, Everaert I, Zwaenepoel O, Vandekerckhove J, Cuvelier C, et al. Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model. Mol Ther. 2014;22:1768–78.
   PubMed Web of Science ®Google Scholar
• Van Overbeke W, Wongsantichon J, Everaert I, Verhelle A, Zwaenepoel O, Loonchanta A, et al. An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model. Hum Mol Genet. 2015;24:2492–507.
   PubMed Web of Science ®Google Scholar
• Meretoja J. Inherited systemic amyloidosis with lattice corneal dystrophy. Vammala: Vammalan Kirjapaino, 1973.
   Google Scholar
• Kiuru S, Salonen O, Haltia M. Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol. 1999;45:305–11.
   PubMed Web of Science ®Google Scholar
• Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4:173–85.
   PubMed Web of Science ®Google Scholar
• Maury C, Kere J, Tolvanen R, De la Chapelle A. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics. 1992;13:902–3.
   PubMed Web of Science ®Google Scholar
• Chastan N, Baert‐Desurmont S, Saugier‐Veber P, Dérumeaux G, Cabot A, Frébourg T, et al. Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p.Asp187Tyr mutation in the GSN gene. Muscle Nerve. 2006;33:113–9.
   PubMed Web of Science ®Google Scholar
• Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5:55–66.
   PubMed Web of Science ®Google Scholar
• Laine A, Kääriäinen H, Notkola IL, Kiuru-Enari S. Perinnöllinen Meretojan tauti. Runsas oirekirjo heikentää elämänlaatua ja lisää terveyspalvelujen käyttöä. Suom Laakaril. 2010;65:1417–23.
   Google Scholar
• Kantanen M, Kiuru-Enari S, Salonen O, Kaipainen M, Hokkanen L. Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis). Peer J. 2014;2:e493.
   Google Scholar
• Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S. Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg. 2011;127:2342–51.
   PubMed Web of Science ®Google Scholar
• Official Statistics of Finland (OSF): Causes of death [Internet]. ISSN =1799-5078. 2005, The key between the short list in the time series of the causes of death since 1969 and the earlier classifications: Helsinki: Statistics Finland [cited 2015 Aug 15]. Available at: http://www.stat.fi/til/ksyyt/2005/ksyyt_2005_2006-10-31_luo_002_en.html.
   Google Scholar
• Hennekens CH, Buring JE, Mayrent SL. Epidemiology in medicine. Boston: Little Brown and Company. 1987.
   Google Scholar
• Official Statistics of Finland (OSF): Deaths [e-publication]. ISSN =1798-2545: Helsinki: Statistics Finland [cited 2015 Dec 15]. Available at: http://www.stat.fi/til/kuol/index_en.html.
   Google Scholar
• Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. APMIS. 1971;79:432–40.
   Google Scholar
• Makishita H, Ikeda SI, Yazaki M, Yamane M, Yumoto KK, Maury C, et al. Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid. 1996;3:134–9.
   Web of Science ®Google Scholar
• Paunio T, Kiuru S, Karonen SL, Palo J, Peltonen L. Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid. 1994;1:80–9.
   Web of Science ®Google Scholar
• Peddada N, Sagar A, Garg R. Plasma gelsolin: a general prognostic marker of health. Med Hypotheses. 2012;78:203–10.
   PubMed Web of Science ®Google Scholar
• Sun HQ, Yamamoto M, Mejillano M, Yin HL. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem. 1999;274:33179–82.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol. 1999;11:103–8.
   PubMed Web of Science ®Google Scholar
• Vouyiouklis DA, Brophy PJ. A novel gelsolin isoform expressed by oligodendrocytes in the central nervous system. J Neurochem. 1997;69:995–1005.
   PubMed Web of Science ®Google Scholar
• Kuzumaki N, Fujita H, Tanaka M, Sakai N, Ohtsu M, Maruta H, et al. In: Maruta H, Kazuhiro K, eds. G proteins, cytoskeleton and cancer, pp. 121–31. Austin, TX: R.G. Landes Company, 1998.
   Google Scholar
• Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, et al. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 1996;56:4841–5.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Sazawa A, Shinohara N, Kobayashi Y, Fujioka Y, Koyanagi T, et al. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice. Cancer Gene Ther. 1999;6:482–7.
   PubMed Web of Science ®Google Scholar
• Chen P, Murphy-Ullrich JE, Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol. 1996;134:689–98.
   PubMed Web of Science ®Google Scholar
• Lader AS, Lee JJ, Cicchetti G, Kwiatkowski DJ. Mechanisms of gelsolin-dependent and -independent EGF-stimulated cell motility in a human lung epithelial cell line. Exp Cell Res. 2005;307:153–63.
   PubMed Web of Science ®Google Scholar
• Deng B, Fang J, Zhang X, Qu L, Cao Z, Wang B. Role of gelsolin in cell proliferation and invasion of human hepatocellular carcinoma cells. Gene. 2015;571:292–7.
   PubMed Web of Science ®Google Scholar
• Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, et al. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 1998;58:322–7.
   PubMed Web of Science ®Google Scholar
• Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sidransky D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res. 1994;54:2322–6.
   PubMed Web of Science ®Google Scholar
• Official Statistics of Finland (OSF): Causes of death [Internet]. ISSN =1799-5078: Helsinki: Statistics Finland [cited 2015 Jul 15]. Available at: http://www.stat.fi/til/ksyyt/tau_en.html.
   Google Scholar